These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 10764313

  • 1. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
    Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE.
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
    [Abstract] [Full Text] [Related]

  • 2. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa.
    Lang BJ, Aaron SD, Ferris W, Hebert PC, MacDonald NE.
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2241-5. PubMed ID: 11112146
    [Abstract] [Full Text] [Related]

  • 3. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
    Manno G, Ugolotti E, Belli ML, Fenu ML, Romano L, Cruciani M.
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.
    Bonacorsi S, Fitoussi F, Lhopital S, Bingen E.
    Antimicrob Agents Chemother; 1999 Feb; 43(2):213-7. PubMed ID: 9925508
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL, Kaufmann ME, Patel PS, Benge LC, Gaskin S, Livermore DM.
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
    Zhou J, Chen Y, Tabibi S, Alba L, Garber E, Saiman L.
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
    Blumer JL, Saiman L, Konstan MW, Melnick D.
    Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
    [Abstract] [Full Text] [Related]

  • 9. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF, McElnay JC, Elborn JS, Tunney MM.
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [Abstract] [Full Text] [Related]

  • 10. Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis.
    St Denis M, Ramotar K, Vandemheen K, Tullis E, Ferris W, Chan F, Lee C, Slinger R, Aaron SD.
    Chest; 2007 Apr; 131(4):1188-96. PubMed ID: 17426227
    [Abstract] [Full Text] [Related]

  • 11. Burkholderia cepacia infections in cystic fibrosis.
    Burns JL, Saiman L.
    Pediatr Infect Dis J; 1999 Feb; 18(2):155-6. PubMed ID: 10048690
    [No Abstract] [Full Text] [Related]

  • 12. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP, Brownlee KG, Denton M, Peckham DG.
    Am J Respir Med; 2003 Feb; 2(4):321-32. PubMed ID: 14719998
    [Abstract] [Full Text] [Related]

  • 13. Novel antibiotic combinations proposed for treatment of Burkholderia cepacia complex infections.
    El-Halfawy OM, Naguib MM, Valvano MA.
    Antimicrob Resist Infect Control; 2017 Feb; 6():120. PubMed ID: 29204272
    [Abstract] [Full Text] [Related]

  • 14. Use of breakpoint combination sensitivity testing as a simple and convenient method to evaluate the combined effects of ceftazidime and tobramycin on Pseudomonas aeruginosa and Burkholderia cepacia complex isolates in vitro.
    Tunney MM, Scott EM.
    J Microbiol Methods; 2004 Apr; 57(1):107-14. PubMed ID: 15003693
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
    Lu DC, Chang SC, Chen YC, Luh KT, Hsieh WC.
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
    [Abstract] [Full Text] [Related]

  • 16. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy.
    Kuti JL, Moss KM, Nicolau DP, Knauft RF.
    Pharmacotherapy; 2004 Nov; 24(11):1641-5. PubMed ID: 15537567
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.
    Weidmann A, Webb AK, Dodd ME, Jones AM.
    J Cyst Fibros; 2008 Sep; 7(5):409-11. PubMed ID: 18356119
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.